Prodrugs of Neurosteroid Analogs and Uses Thereof
AssigneeEmory University
InventorsDennis Liotta, Russell Fritzemeier, Alet van der Westhuyzen, Luke E. Hodson
Life of this patent
Estimating the term…
Abstract
Prodrugs of neurosteroid analogs are disclosed. Pharmaceutical formulations containing the prodrugs are also disclosed, Additionally, methods of treating a condition, disorder, or disease using the prodrugs or their pharmaceutical formulations are disclosed. Exemplary conditions, disorders, and diseases relevant to this disclosure include stroke, subarachnoid hemorrhage, cerebral ischemia, cerebral vasospasm, hypoxia, CNS injury, concussion, traumatic brain injury, depression, postpartum depression, epilepsy, seizure disorder, and neurodegenerative disease.
Claims32
A compound of Formula II or a pharmaceutically acceptable salt, hydrate, or hydrated salt thereof,
- wherein n is 0 or 1;
- and
- wherein:
- (1) X is OH or NR1R2,
- Y is O or NR3,
- RA, RB, RC, RD, RE, and RF are independently selected from the group consisting of hydrogen, halogen, cyano, nitro, carboxyl, carbonate, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, acyl, sulfinyl, sulfonyl, sulfonate, sulfonamide, amide, optionally Si-substituted silyl, ester, thioester, carbonate ester, and carbamate, and
- R1, R2, and R3 are independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted heteroalkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, and optionally substituted heteroaryl, with the proviso that at least one of R1 and R2 is hydrogen;
- (2) X is NR1R2,
- Y is O or NR3,
- R1 joins RC or RE to form a 4-7 membered, optionally substituted heterocycle,
- R2 is hydrogen,
- RA, RB, RC, RD, RE, and RF, on each occurrence when not joined by R1 to form the heterocycle, are independently selected from the group consisting of hydrogen, halogen, cyano, nitro, carboxyl, carbonate, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, acyl, sulfinyl, sulfonyl, sulfonate, sulfonamide, amide, optionally Si-substituted silyl, ester, thioester, carbonate ester, and carbamate, and
- R3 is independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted heteroalkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, and optionally substituted heteroaryl;
- or
- (3) X is OH or NR1R2,
- Y is NR3,
- R3 joins RA to form a 4-7 membered, optionally substituted heterocycle,
- RB, RC, RD, RE, and RF are independently selected from the group consisting of hydrogen, halogen, cyano, nitro, carboxyl, carbonate, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, acyl, sulfinyl, sulfonyl, sulfonate, sulfonamide, amide, optionally Si-substituted silyl, ester, thioester, carbonate ester, and carbamate, and
- R1 and R2 are independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted heteroalkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, and optionally substituted heteroaryl, with the proviso that at least one of R1 and R2 is hydrogen.
(canceled)
(canceled)
(canceled)
(canceled)
12-16. (canceled)
(canceled)
21-23. (canceled)
(canceled)
(canceled)
29-33. (canceled)
35-59. (canceled)
63-66. (canceled)
Dependencies are inferred from the claim text.